10 March 2010
Successful completion of first-in-man study with EVT 103 - Positive feedback from the FDA to initiate Phase II with EVT 101...
25 February 2010
Collaboration expanded to include integrated fragment-based drug discovery activities on additional antibacterial targets: Evotec AG today announced that it has extended its research agreement with Cubist Pharmaceuticals, Inc...
1 March 2010: Evotec AG going to broadcast its press & analyst conference in Frankfurt live on the internet. The Management Board of Evotec AG will inform you about the ...
- read more